A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00399230
First received: November 9, 2006
Last updated: August 17, 2007
Last verified: August 2007
  Purpose

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.


Condition Intervention Phase
Dry Eye
Drug: Optive
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Innovative Medical:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • · Dry eye disease diagnosis

    • Patients must currently be using Systane tears at least once a day and for at least 1 month.
    • Normal lid position and closure
    • Male or female of legal age of consent
    • Informed consent has been obtained
    • Likely to complete all required follow-up visits

Exclusion Criteria:

  • · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.

    • Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00399230

Locations
United States, Virginia
Dr. Rajpal
McLean, Virginia, United States, 22102
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Rajesh Rajpal, MD See Clearly Vision Group
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00399230     History of Changes
Other Study ID Numbers: 5279
Study First Received: November 9, 2006
Last Updated: August 17, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Keratoconjunctivitis Sicca
Dry Eye Syndromes
Keratoconjunctivitis
Conjunctivitis
Conjunctival Diseases
Eye Diseases
Keratitis
Corneal Diseases
Lacrimal Apparatus Diseases

ClinicalTrials.gov processed this record on April 16, 2014